Conference Reports for NATAP

The International Liver Congress™ EASL 2017 - European Association for the Study of the Liver Amsterdam, The Netherlands. 2017 Back

HCV clearance after direct-acting antivirals in cirrhotic [advanced] patients by stages of liver impairment: the ITAL-C network study       Reported by Jules Levin EASL 2017 April 19-23 Amsterdam Netherlands   Antonio Massimo Ippolito1, Michele Milella2, Vincenzo Messina3, Fabio Conti4, Raffaele Cozzolongo5, Filomena Morisco6, Giuseppina Brancaccio7, Michele Barone8, Teresa Santantonio9, Massimo Fasano9, Chiara Masetti10, Paolo Tundo11, Antonina Smedile12, Vito Carretta13, Pietro Gatti14, Antonio Patrizio Termite15, Maria Rosa Valvano1, Giuseppe Bruno2, Claudia Fabrizio2, Pietro Andreone4, Marianna Zappimbulso5, Giovanni Battista Gaeta7, Nicola Napoli16, Luca Fontanella17, Gianfranco Lauletta18, Giuseppe Cuccorese19, Antonio Metrangolo20, Ruggiero Francavilla21, Emanuela Ciracì14, Salvatore Rizzo22, Angelo Andriulli1 1Casa Sollievo Sofferenza Hospital, San Giovanni Rotondo; 2University of Bari; 3S. Anna and S. Sebastiano Hospital, Caserta; 4Universityof Bologna; 5De BellisHospital, Castellana Grotte; 6Division ofGastroenterologyFederico II Universityof Napoli; 7Clinical of InfectiousDiseaseFederico II Universityof Napoli; 8AOU Policlinico, Universityof Bari; 9Universityof Foggia; 10Universityof Tor Vergata, Roma; 11Hospital of Galatina; 12Universityof Torino, Azienda Ospedaliera Città della Salute e della Scienza, Torino; 13Liver Unit, Hospital of Venosa; 14Hospital of Ostuni; 15Hospital of Castellaneta; 16C. Frugoni, Universityof Bari; 17Fatebenefratelli Hospital, Napoli; 18Clinics of InternalMedicine "G. Baccelli", Universityof Bari; 19Hospital, Barletta; 20Hospital of Casarano; 21Hospital of Bisceglie; 22Hospital of Martina Franca.